Antineoplastic drug contamination and safe handling practices in Canadian healthcare centres: Results from the 2025 monitoring program
- 27 January 2026
- journal article
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
Abstract
Introduction: Occupational exposure to antineoplastic drugs remains a significant concern for healthcare workers. Surface contamination is a key indicator of exposure risks and reflects the effectiveness of practices. This study aimed to describe contamination with 11 antineoplastic drugs on 12 surfaces in Canadian healthcare centres participating in the 2025 monitoring program and to examine practices implemented by these centres, including the potential influence of hazardous drug committees. Methods: Each centre sampled six standardized sites in oncology pharmacies and six in outpatient clinics. Ultra-performance liquid chromatography-tandem mass spectrometry quantified cyclophosphamide, docetaxel, doxorubicin, etoposide, 5-fluorouracil, gemcitabine, irinotecan, methotrexate, paclitaxel and vinorelbine. Inductively coupled plasma mass spectrometry quantified platinum-based drugs. The Kolmogorov–Smirnov test assessed differences in contamination, and chi-square tests compared practice implementation. Results: A total of 127 centres participated. Overall, 35% (504/1 453) of surfaces were contaminated, most frequently cyclophosphamide (22%, 90 th percentile 0.0052 ng/cm 2 ) and gemcitabine (14%, 0.0017 ng/cm 2 ). The most contaminated sites were the front grille inside the biological safety cabinet (70%) and the armrest of the treatment chair (67%). More than half of centres (67/122, 55%) reported having a hazardous drugs committee. Cyclophosphamide surface contamination differed by committee presence and meeting frequency ( p = 0.034). Centres with a committee were more likely to implement certain handling practices, including cleaning vials before storage ( p = 0.004). Conclusions: Surface contamination remains frequent but at low concentrations, with evidence of improvement over time. Multidisciplinary committees, continuous monitoring and broader staff engagement are essential to strengthen safety culture and reduce occupational exposure.Keywords
This publication has 22 references indexed in Scilit:
- Systematic Review Examining the Effectiveness of Professional, Organisational and Structural Interventions in Primary Care to Reduce Medication-Related Hospitalisations and DeathsDrug Safety, 2025
- Experimental protocols and models for assessing the permeation of antineoplastic drugs through gloves: From a scoping review to a guidelines proposition for future studiesJournal of Hazardous Materials, 2025
- Buccal micronucleus cytome assay to evaluate cyto-genotoxic effects of occupational exposure to antineoplastic drugs: application on a large sample size of workers furnished by an Italian network of oncological hospitalsArchives of Toxicology, 2025
- Gloves Standards and Occupational Exposure to Antineoplastic Drugs in the European ContextHealth Science Reports, 2025
- Antineoplastic drugs in healthcare settings: Occupational exposure and risk graduationEmerging Contaminants, 2025
- Ensuring safety in cytotoxic drug preparation: A systematic review of guidelines addressing education for pharmacy professionalsJournal of the American Pharmacists Association, 2025
- Knowledge and safe handling practices affecting the occupational exposure of nurses and midwives to hazardous drugs: A mixed methods systematic reviewInternational Journal of Nursing Studies, 2024
- Fastidious chemical decontamination after cyclophosphamide vial breakage in a compounding unitJournal of Oncology Pharmacy Practice, 2020
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Estimation of Average Concentration in the Presence of Nondetectable ValuesApplied Occupational and Environmental Hygiene, 1990